I now have comprehensive information from the textbooks. Let me synthesize a thorough overview of antibiotics.
Antibiotics — Comprehensive Overview
1. What Are Antibiotics?
Antibiotics are chemical agents that kill or inhibit the growth of bacteria. They are classified as:
- Bactericidal — kill bacteria directly (e.g., beta-lactams, fluoroquinolones, aminoglycosides)
- Bacteriostatic — inhibit bacterial growth, relying on host immunity to clear infection (e.g., tetracyclines, macrolides, sulfonamides)
2. Major Classifications & Mechanisms of Action
🔵 A. Beta-Lactams (Bactericidal)
Mechanism: Interfere with bacterial cell wall peptidoglycan synthesis by binding to penicillin-binding proteins (PBPs).
All share a β-lactam ring with structural variations:
| Subclass | Examples | Spectrum |
|---|
| Natural Penicillins | Penicillin G, Penicillin V | Gram-positive (streptococci, syphilis) |
| Aminopenicillins | Ampicillin, Amoxicillin | Broader Gram-positive + some Gram-negative |
| Antistaphylococcal | Nafcillin, Oxacillin | MSSA (not MRSA) |
| Antipseudomonal Penicillins | Piperacillin, Ticarcillin | Pseudomonas aeruginosa |
| Beta-lactam + inhibitor combos | Amoxicillin-clavulanate, Piperacillin-tazobactam, Ampicillin-sulbactam | Broad-spectrum, overcomes beta-lactamase resistance |
| Cephalosporins (1st–5th gen) | Cephalexin → Ceftaroline | Progressively broader Gram-negative coverage |
| Carbapenems | Imipenem, Meropenem, Ertapenem, Doripenem | Broadest spectrum (Gram+, Gram−, anaerobes, Pseudomonas) |
| Monobactams | Aztreonam | Gram-negative only; safe in penicillin allergy |
"β-Lactam antibiotics are bactericidal agents that interfere with the synthesis of bacterial cell-wall peptidoglycans by binding to bacterial penicillin-binding proteins." — Fishman's Pulmonary Diseases and Disorders
🟢 B. Aminoglycosides (Bactericidal)
Mechanism: Bind to the 30S ribosomal subunit → inhibit protein synthesis → misreading of mRNA.
Examples: Gentamicin, Tobramycin, Amikacin, Streptomycin
Spectrum: Gram-negative bacilli, synergistic with beta-lactams for serious infections
Side effects: Nephrotoxicity, ototoxicity (irreversible)
🟡 C. Macrolides (Bacteriostatic)
Mechanism: Bind 50S ribosomal subunit → block translocation during protein synthesis.
Examples: Azithromycin, Clarithromycin, Erythromycin
Spectrum: Gram-positive cocci, atypical organisms (Mycoplasma, Chlamydia, Legionella)
Side effects: GI upset, QTc prolongation, drug interactions (CYP450 inhibition)
🔴 D. Fluoroquinolones (Bactericidal)
Mechanism: Inhibit DNA gyrase and topoisomerase IV → promote DNA strand breakage.
Examples:
- Ciprofloxacin — Gram-negative bacilli, Pseudomonas, atypicals
- Levofloxacin — MSSA, Streptococcus sp., Gram-negatives, atypicals
- Moxifloxacin — MSSA, Streptococcus, anaerobes, atypicals
Side effects: Stevens-Johnson syndrome, QTc prolongation, tendinitis/tendon rupture, arthropathy, avoid in children (cartilage toxicity)
"Inhibit DNA gyrase and bacterial topoisomerase IV that promotes DNA strand breakage." — K.J. Lee's Essential Otolaryngology
🟤 E. Tetracyclines (Bacteriostatic)
Mechanism: Bind 30S ribosomal subunit → block aminoacyl-tRNA binding.
Examples: Doxycycline, Tetracycline, Minocycline, Tigecycline
Spectrum: Broad — Gram-positive, Gram-negative, atypicals, rickettsiae, spirochetes
Side effects: Photosensitivity, GI upset, teeth discoloration (avoid in children <8 years and pregnancy), esophageal irritation
⚪ F. Glycopeptides (Bactericidal)
Mechanism: Bind to D-Ala-D-Ala terminus of peptidoglycan precursors → block cell wall synthesis (different site than beta-lactams).
Examples: Vancomycin, Teicoplanin
Spectrum: Gram-positive only — MRSA, Clostridioides difficile (oral vancomycin)
Side effects: "Red man syndrome" (histamine release — infuse slowly), nephrotoxicity, ototoxicity
🟠 G. Sulfonamides & Trimethoprim (Bacteriostatic)
Mechanism:
- Sulfonamides: Inhibit dihydropteroate synthase → block folic acid precursor synthesis
- Trimethoprim: Inhibits dihydrofolate reductase → blocks folic acid activation
- Combined as TMP-SMX: Synergistic double blockade of folate pathway
Uses: Pneumocystis jirovecii pneumonia (PCP), UTIs, community-acquired MRSA skin infections
Side effects: Rash, GI upset, renal failure (especially elderly), Stevens-Johnson syndrome, bone marrow suppression
🟣 H. Lincosamides (Bacteriostatic)
Mechanism: Bind 50S ribosomal subunit → inhibit peptide bond formation.
Example: Clindamycin
Spectrum: Gram-positive, anaerobes
Side effects: C. difficile colitis (pseudomembranous colitis)
🔶 I. Other Important Classes
| Class | Example | Mechanism | Key Use |
|---|
| Oxazolidinones | Linezolid | 50S ribosome inhibitor | MRSA, VRE |
| Lipopeptides | Daptomycin | Disrupts cell membrane phospholipid bilayer | MRSA, VRE (not pneumonia — inactivated by surfactant) |
| Nitroimidazoles | Metronidazole | DNA strand breakage via free radicals | Anaerobes, C. diff, protozoa |
| Rifamycins | Rifampicin | Inhibit RNA polymerase | TB, Mycobacteria |
| Nitrofurans | Nitrofurantoin | DNA damage | Uncomplicated UTI only |
| Polymyxins | Colistin, Polymyxin B | Disrupt outer membrane | Multidrug-resistant Gram-negatives |
3. Antibiotic Resistance Mechanisms
Bacteria resist antibiotics through 5 key strategies:
| # | Mechanism | Example |
|---|
| 1 | Enzymatic destruction | Beta-lactamase hydrolyzes penicillins/cephalosporins |
| 2 | Target modification | PBP2a (mecA gene in MRSA) reduces beta-lactam binding; mutated DNA gyrase resists fluoroquinolones |
| 3 | Reduced permeability | Porin channel loss in Pseudomonas aeruginosa |
| 4 | Efflux pumps | Active expulsion of antibiotics (tetracyclines, fluoroquinolones in Gram-negatives) |
| 5 | Biofilm formation | Extracellular polymeric substance reduces antibiotic penetration |
"PBP2a — confers penicillin and cephalosporin resistance via plasmid gene mecA in methicillin-resistant Staphylococcus aureus (MRSA)." — K.J. Lee's Essential Otolaryngology
4. Spectrum Summary
| Coverage | Antibiotic of Choice |
|---|
| Gram-positive (MSSA) | Nafcillin, Cefazolin |
| MRSA | Vancomycin, Linezolid, Daptomycin |
| Gram-negative | Aminoglycosides, Cephalosporins (3rd/4th gen), Fluoroquinolones |
| Pseudomonas | Piperacillin-tazobactam, Cefepime, Carbapenems (imipenem/meropenem), Ciprofloxacin |
| Anaerobes | Metronidazole, Clindamycin, Moxifloxacin, Carbapenems |
| Atypicals | Azithromycin, Doxycycline, Levofloxacin |
| ESBL Gram-negatives | Carbapenems |
| VRE | Linezolid, Daptomycin |
| TB/Mycobacteria | Rifampicin + INH + PZA + Ethambutol |
5. Key Clinical Pearls
- Penicillin allergy: If mild (rash), cephalosporins can usually be used (1–2% cross-reactivity). If severe (anaphylaxis), use aztreonam for Gram-negatives or vancomycin for Gram-positives.
- Renal dose adjustment: Required for aminoglycosides, vancomycin, beta-lactams, TMP-SMX, nitrofurantoin (avoid in severe renal failure).
- Pregnancy safety: Penicillins and cephalosporins are safest. Avoid tetracyclines, fluoroquinolones, aminoglycosides, TMP-SMX (1st trimester).
- Narrow-spectrum preferred: Always target the specific pathogen when known — reduces resistance and side effects.
- Duration matters: Incomplete courses contribute to resistance; however, shorter courses are now preferred when evidence supports them.
6. Common Side Effects Quick Reference
| Antibiotic | Key Adverse Effect |
|---|
| Aminoglycosides | Nephrotoxicity, ototoxicity |
| Vancomycin | Red man syndrome, nephrotoxicity |
| Fluoroquinolones | Tendon rupture, QTc prolongation |
| Clindamycin | C. difficile colitis |
| Tetracyclines | Photosensitivity, tooth discoloration |
| Macrolides | QTc prolongation, drug interactions |
| TMP-SMX | Rash, renal failure, bone marrow suppression |
| Daptomycin | Myopathy (monitor CPK), avoid in pneumonia |
| Metronidazole | Metallic taste, peripheral neuropathy, disulfiram-like reaction with alcohol |
| Rifampicin | Orange body secretions, potent CYP inducer, hepatotoxicity |
| Nitrofurantoin | Pulmonary toxicity (long-term), peripheral neuropathy |
Sources: K.J. Lee's Essential Otolaryngology; Fishman's Pulmonary Diseases and Disorders; Medical Microbiology 9e; Current Surgical Therapy 14e